The DH&L was the first in the Netherlands to implant the Parachute-III device into the heart of a patient with ischemic heart failure. An Interventional Cardiologist uses a catheter to guide the material through the coronary artery and the aortic valve to the correct place. The parachute is then deployed to create a partition between the good and bad parts of the heart. The aneurysmatic tissue no longer participates in heart function so that blood can no longer accumulate there.

The DH&L at the UMC Utrecht is the first hospital in the Netherlands to have a bedside device that can test patients' oral mucosa to establish within the hour whether patients have a certain gene variant. Patients undergoing angioplasty after a heart attack need blood-thinners to reduce the risk of new constrictions in their blood vessels. This test allows cardiologists to choose the correct dose and type of blood-thinners immediately.